The melanosome: The perfect model for cellular responses to the environment

Pigment Cell Research

Volumn 13, Issue SUPPL. 8, 2000, Pages 23-34

  Hearing, Vincent J ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Melanin; Melanoma; Photoabsorption; Pigmentation

Indexed keywords

CATECHOLAMINE; MELANIN; NEUROMELANIN; PHEOMELANIN;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; BIOSYNTHESIS; ENVIRONMENT; HUMAN; INTRACELLULAR FLUID; MELANOMA; MELANOSOME; METABOLISM; UPREGULATION;

ANIMALS; CATECHOLAMINES; ENVIRONMENT; HUMANS; INTRACELLULAR FLUID; MELANINS; MELANOMA; MELANOSOMES; MODELS, BIOLOGICAL; UP-REGULATION;

EID: 0034566124     PISSN: 08935785     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0749.13.s8.7.x     Document Type: Article

References (79)

1. Nordlund JJ, Boissy RE, Hearing VJ, King RA, Ortonne JP. The Pigmentary System: Physiology and Pathophysiology. New York: Oxford Univ Press; 1998. pp. 1-1025
2. Hearing VJ, Tsukamoto K. Enzymatic control of pigmentation in mammals. FASEB J 1991;5:2902-2909
3. Hearing VJ. Unraveling the melanocyte. Amer J Hum Gen 1993;52:1-7
4. Hearing VJ, King RA. Determinants of skin color: Melanocytes and melanization. In: Levine N. Pigmentation and Pigmentary Abnormalities. New York: CRC Press; 1993. pp. 3-32
5. Spritz RA, Hearing VJ. Genetic disorders of pigmentation. In: Hirschhorn K, Harris H. Advances in Human Genetics. New York: Plenum Press; 1994. pp. 1-45
6. King RA, Oetting WS, Hearing VJ. Albinism. In: Scriver CR, Beaudet AL, Sly WS, Valle D. Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill; 1995. pp. 4353-4392
7. Hearing VJ. Regulatory mechanisms of pigmentation. In: Hori W. Drug Discovery Approaches for Developing Cosmeceuticals, Advanced Skin Care and Cosmetic Products. Southborough: IBC Library Series; 1997. pp. 3.1.1-3.1.21
8. King RA, Hearing VJ, Getting WS. Abnormalities of pigmentation. In: Rimoin DL, Connor JM, Pyeritz RE. Emery and Rimoin's Principles and Practice of Medical Genetics. 3rd ed. New York: Churchill Livingstone; 1997. pp. 1171-1203
9. Hearing VJ. The regulation of melanin production. In: Nordlund JJ, Boissy RE, Hearing VJ, King RA, Ortonne JP. The Pigmentary System: Physiology and Pathophysiology. New York: Oxford University Press; 1998. pp. 423-438
10. Spritz RA, Ho L, Furumura M, Hearing VJ. Mutational analysis of copper-binding by human tyrosinase. J Invest Dermatol 1997;109:207-212
11. Furumura M, Solano F, Matsunaga N, Sakai C, Spritz RA, Hearing VJ. Metal ligand binding specificities of the tyrosinase related proteins. Biochem Biophys Res Commun 1998;242:579-585
12. Kobayashi T, Urabe K, Orlow SJ, Higashi K, Imokawa G, Kwon BS, Potterf SB, Hearing VJ. The pmel17/silver locus protein: Characterization of its role in mammalian melanogenesis. J Biol Chem 1994;269:29198-29205
13. Hearing VJ, Kobayashi T, Urabe K, Potterf SB, Kameyama K. The characteristics of biological melanins are influenced at multiple points in the melanogenic pathway. In: Zeise L, Chedekel MR, Fitzpatrick TB. Melanin: Its Role in Human Photoprotection. Overland Park: Valdenmar Publ; 1995. pp. 117-124
14. Kameyama K, Sakai C, Kuge S, Nishiyama S, Tomita Y, Ito S, Wakamatsu K, Hearing VJ. Expression of tyrosinase, tyrosinase-related proteins 1 and 2 (TRP1 and TRP2), silver protein and a melanogenic inhibitor regulates melanogenesis in human melanoma cells. Pigment Cell Res 1995;8:97-104
15. Palumbo A, DiCosmo A, Gesualdo I, Hearing VJ. Subcellular localization and interaction of melanogenic enzymes in the ink gland of Sepia officinalis. Biochem J 1997;323:749-756
16. Hearing VJ. Biochemical control of melanogenesis and melanosomal organization. J Invest Dermatol 1999;Suppl 4:24-28
17. Jiménez-Cervantes C, Solano F, Kobayashi T, Urabe K, Hearing VJ, Lozano JA, García-Borrón JC. A new enzymatic function in the melanogenic pathway: The 5,6-dihydroxyindole-2-carboxylic acid oxidase activity of tyrosinase-related protein-1 (TRP1). J Biol Chem 1994;269:17993-18001
18. Kobayashi T, Urabe K, Winder AJ, Jiménez-Cervantes C, Imokawa G, Brewington T, Solano F, García-Borrón JC, Hearing VJ. Tyrosinase related protein 1 (TRP1) functions as a DHICA oxidase in melanin biosynthesis. EMBO J 1994;13:5818-5825
19. Ozeki H, Ito S, Wakamatsu K, Hirobe T. Chemical characterization of hair melanins in various coat-color mutants of mice. J Invest Dermatol 1995;105:361-366
20. Boissy RE, Sakai C, Zhao H, Kobayashi T, Hearing VJ. Human tyrosinase related protein-1 (TRP-1) does not function as a DHICA oxidase in contrast to murine TRP-1. Exp Dermatol 1998;7:198-204
21. Boissy RE, Zhao H, Oetting WS, Austin LM, Wildenberg SC, Boissy YL, Zhao Y, Sturm RA, Hearing VJ, King RA, Nordlund JJ. Mutation in and lack of expression of tyrosinase related protein 1 (TRP1) in melanocytes from an individual with brown oculocutaneous albinism: A new subtype of albinism classified as OCA3. Amer J Hum Gen 1996;58:1145-1156
22. Kobayashi T, Imokawa G, Bennett DC, Hearing VJ. Tyrosinase stabilization by Tyrp1 (the brown locus protein). J Biol Chem 1998;273:31801-31805
23. Gahl WA, Potterf SB, Durham-Pierre D, Brilliant MH, Hearing VJ. Melanosomal tyrosine transport in normal and pinkeyed dilution murine melanocytes. Pigment Cell Res 1995;8:229-233
24. Potterf SB, Muller J, Bernardini I, Tietze F, Kobayashi T, Hearing VJ, Gahl WA. Characterization of a melanosomal transport system in murine melanocytes mediating entry of the melanogenic substrate tyrosine. J Biol Chem 1996;271:4002-4008
25. Potterf SB, Virador V, Wakamatsu K, Furumura M, Santis C, Ito S, Hearing VJ. Cysteine transport in melanosomes from murine melanocytes. Pigment Cell Res 1999;12:4-12
26. Potterf SB, Hearing VJ. Tyrosine transport into melanosomes is increased following stimulation of melanocyte differentiation. Biochem Biophys Res Commun 1998;248:795-800
27. Potterf SB, Furumura M, Sviderskaya EV, Sakai C, Bennett DC, Hearing VJ. Normal tyrosine transport and abnormal tyrosinase routing in pinkeyed-dilution melanocytes. Exp Cell Res 1998;244:319-326
28. Puri N, Brilliant MH. The function of the pink-eyed dilution protein. Pigment Cell Res 1998;11:174-175
29. Kobayashi T, Vieira WD, Potterf SB, Sakai C, Imokawa G, Hearing VJ. Modulation of melanogenic protein expression during the switch from eu- to pheomelanogenesis. J Cell Sci 1995;108:2301-2309
30. Sakai C, Ollmann M, Kobayashi T, Abdel-Malek ZA, Muller J, Vieira WD, Imokawa G, Barsh GS, Hearing VJ. Modulation of murine melanocyte function in vitro by agouti signal protein. EMBO J 1997;16:3544-3552
31. Suzuki I, Tada A, Ollmann M, Barsh GS, Im S, Lamoreux ML, Hearing VJ, Nordlund JJ, Abdel-Malek ZA. Agouti signalling protein inhibits melanogenesis and the response of human melanocytes to α-melanotropin. J Invest Dermatol 1997;108:838-842
32. Furumura M, Sakai C, Potterf SB, Vieira W, Barsh GS, Hearing VJ. Characterization of genes modulated during pheomelanogenesis using differential display. Proc Natl Acad Sci USA 1998;95:7374-7378
33. Lu D, Willard D, Patel IR, Kadwell S, Overton L, Kost T, Luther M, Chen W, Woychik RP, Wilkison WO, Cone RD. Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature 1994;371:799-802
34. Barsh GS. The genetics of pigmentation: From fancy genes to complex traits. Trends Genet 1996;12:299-305
35. Suzuki I, Cone RD, Im S, Nordlund JJ, Abdel-Malek ZA. Binding of melanotropic hormones to the melanocortin receptor MC1 on human melanocytes stimulates proliferation and melanogenesis. Endocrinology 1996;137:1627-1633
36. Ollmann MM, Lamoreux ML, Wilson BD, Barsh GS. Interaction of agouti protein with the melanocortin 1 receptor in vitro and in vivo. Genes & Devel 1998;12:316-330
37. Prota G. Melanins and Melanogenesis. New York: Academic Press; 1992. pp. 1-290
38. Chedekel MR, Zeise L. Sunlight, melanogenesis and radicals in the skin. Lipids 1988;23:587-591
39. Kobayashi N, Nakagawa A, Muramatsu T, Yamashina Y, Shirai T, Hashimoto MW, Ishigaki Y, Ohnishi T, Mori T. Supranuclear melanin caps reduce ultraviolet induced DNA photoproducts in human epidermis. J Invest Dermatol 1998;110:806-810
40. Silvers WK. The Coat Colors of Mice: A Model for Mammalian Gene Action and Interaction. Basel: Springer-Verlag; 1979. pp. 1-380
41. Valverde P, Healy E, Jackson IJ, Rees JL, Thody AJ. Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nature Genet 1995;11:328-330
42. Krude H, Biebermann H, Luck W, Horn R, Brabant G, Gruters A. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nature Genet 1998;19:155-157
43. Sturm RA, Box NF, Ramsay M. Human pigmentation genetics: The difference is only skin deep. Bioessays 1998;20:712-721
44. Prota G, Lamoreux ML, Muller J, Kobayashi T, Napolitano A, Vincenzi R, Sakai C, Hearing VJ. Comparative analysis of melanins and melanosomes produced by various coat color mutations. Pigment Cell Res 1995;8:153-163
45. Abdel-Malek ZA, Swope VB, Suzuki I, Akcali C, Harriger D, Boyce ST, Urabe K, Hearing VJ. Mitogenic and melanogenic stimulation of normal human melanocytes by melanotropic peptides. Proc Natl Acad Sci USA 1995;92:1789-1793
46. Furumura M, Sakai C, Abdel-Malek ZA, Barsh GS, Hearing VJ. The interaction of agouti signal protein and melanocyte stimulating hormone to regulate melanin formation in mammals. Pigment Cell Res 1996;9:191-203
47. Virador V, Santis C, Furumura M, Vieira WD, Hearing VJ. Bioactive motifs of agouti signal protein and the switch between yellow and black melanins. J Biol Chem 1999, in revision.
48. Quillan JM, Sadee W, Wei ET, Jimenez C, Ji L, Chang JK. A synthetic human agouti-related protein (83-132) NH2 fragment is a potent inhibitor of melanocortin receptor function. FEBS Lett 1998;428:59-62
49. Millar SE, Miller MW, Stevens ME, Barsh GS. Expression and transgenic studies of the mouse agouti gene provide insight into the mechanisms by which mammalian coat color patterns are generated. Development 1995;121:3223-3232
50. Matsunaga N, Virador V, Santis C, Vieira WD, Furumura M, Matsunaga J, Hearing VJ. In situ localization of agouti signal protein in murine skin using immunohistochemistry with an ASP-specific antibody. Biochem Biophys Res Commun 2000;270:176-182
51. Yasumoto K, Mahalingam H, Suzuki H, Yoshizawa M, Yokoyama K, Shibahara S. Transcriptional activation of the melanocyte-specific genes by the human homolog of the mouse microphthalmia protein. J Biochem 1995;118:874-881
52. Opdecamp K, Nakayama A, Nguyen MTT, Hodgkinson CA, Pavan WJ, Arnheiter H. Melanocyte development in vivo and in neural crest cell cultures: Crucial dependence on the Mitf basic-helix-loop-helix-zipper transcription factor. Development 1997;124:2377-2386
53. Bertolotto C, Busca R, Abbe P, Bille K, Aberdam E, Ortonne JP, Ballotti R. Different cis-acting elements are involved in the regulation of TRP1 and TRP2 promoter activities by cyclic AMP: Pivotal role of M boxes (GTCAT-GTGCT) and of microphthalmia. Mol Cell Biol 1998;18:694-702
54. Aberdam E, Bertolotto C, Sviderskaya EV, de Thillot V, Hemesath TJ, Fisher DE, Bennett DC, Ortonne JP, Ballotti R. Involvement of microphthalmia in the inhibition of melanocyte lineage differentiation and of melanogenesis by agouti signal protein. J Biol Chem 1998;273:19560-19565
55. Price ER, Horstmann MA, Wells AG, Weilbaecher KN, Takemoto CM, Landis MW, Fisher DE. Melanocyte-stimulating hormone signaling regulates expression of microphthalmia, a gene deficient in Waardenburg Syndrome. J Biol Chem 1998;273:33042-33047
56. Orlow SJ, Hearing VJ, Sakai C, Urabe K, Zhou BK, Silvers WK, Mintz B. Changes in expression of putative antigens encoded by pigment genes in mouse melanomas at different staees of malignant progression. Proc Natl Acad Sci USA 1995;92:10152-10156
57. Hearing VJ. Melanogenic proteins as specific melanoma antigens. In: Hori Y, Hearing VJ, Nakayama J. Proceedings of the International Symposium on Melanogenesis and Malignant Melanoma. New York: Elsevier; 1996. pp. 135-148
58. Marincola FM, Hijazi YM, Fetsch P, Salgaller ML, Rivoltini L, Cormier J, Simonis TB, Duray P, Herlyn M, Kawakami Y, Rosenberg SA. Analysis of expression of the melanoma-associated antigens MART-1 and gp100 in metastatic melanoma cell lines and in in situ lesions. J Immunother 1996;19:192-205
59. Kawakami Y, Battles JK, Kobayashi T, Wang X, Tupesis JL, Marincola FM, Robbins PF, Hearing VJ, Gonda MA, Rosenberg SA. Production of recombinant MART-1 proteins and specific antiMART-1 polyclonal and monoclonal antibodies: Use in the characterization of the human melanoma antigen MART-1. J Immunol Meth 1997;202:13-25
60. Sakai C, Kawakami Y, Law LW, Furumura M, Hearing VJ. Melanosomal proteins as melanoma specific immune targets. Melanoma Res 1997;7:83-95
61. Soballe PW, Herlyn M. Cellular pathways leading to melanoma differentiation: Therapeutic implications. Melanoma Res 1994;4:213-223
62. Meier F, Satyamoorthy K, Nesbit M, Hsu MY, Schittek A, Garbe C, Herlyn M. Molecular events in melanoma development and progression. Front Biosci 1998;15:D1005-D1010
63. de Vries TJ, Fourkour A, Wobbes T, Verkroost G, Ruiter DJ, van Muijen GNP. Heterogeneeous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions. Cancer Res 1997;57:3223-3229
64. Sarantou T, Chi DDC, Garrison DA, Conrad AJ, Schmid P, Morton DL, Hoon DSB. Melanoma-associated antigens as messenger RNA detection markers for melanoma. Cancer Res 1997;57:1371-1376
65. Sauter ER, Herlyn M. Molecular biology of human melanoma development and progression. Mol Carcinogen 1998;23:132-143
66. Schmidt W, Buschle M, Zauner W, Kirlappos H, Mechtler K, Trska B, Birnstiel ML. Cell-free tumor antigen peptide-based cancer vaccines. Proc Natl Acad Sci USA 1997;94:3262-3267
67. Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL, Restifo NP, Dudley ME, Schwarz SL, Spiess PJ, Wunderlich JR, Parkhurst MR, Kawakami Y, Seipp CA, Einhorn JH, White DE. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nature Med 1998;4:321-327
68. Honing S, Sandoval IV, von Figura K. A di-leucine-based motif in the cytoplasmic tail of LIMP-II and tyrosinase mediates selective binding of AP-3. EMBO J 1998;17:1304-1314
69. Xu Y, Vijayasaradhi S, Houghton AN. The cytoplasmic tail of the mouse brown locus product determines intracellular stability and export from the endoplasmic reticulum. J Invest Dermatol 1998;110:324-331
70. Halaban R, Cheng E, Zhang Y, Moellmann G, Hanlon DP, Michalak M, Vijayasaradhi S, Hebert DN. Aberrant retention of tyrosinase in the endoplasmic reticulum mediates accelerated degradation of the enzyme and contributes to the dedifferentiated phenotype of amelanotic melanoma cells. Proc Natl Acad Sci USA 1997;94:6210-6215
71. Toyofuku K, Wada I, Hirosaki K, Park JS, Hori Y, Jimbow K. Promotion of tyrosinase folding in Cos7 cells by calnexin. J Biochem 1999;125:82-89
72. Branza-Nichita N, Petrescu AJ, Dwek RA, Wormald MR, Platt FM, Petrescu SM. Tyrosinase folding and copper loading in vivo: A crucial role for calnexin and α-glucosidase II. Biochem Biophys Res Commun 1999;261:720-725
73. Rios M, Habecker B, Sasaoka T, Eisenhofer G, Tian H, Landis S, Chikaraishi D, Roffler-Tarlov S. Catecholamine synthesis is mediated by tyrosinase in the absence of tyrosine hydroxylase. J Neurosci 1999;19:3519-3526
74. Tief K, Hahne M, Schmidt A, Beermann F. Tyrosinase, the key enzyme in melanin synthesis, is expressed in murine brain. Eur J Biochem 1996;241:12-16
75. Tief K, Schmidt A, Beermann F. New evidence for presence of tyrosinase in substantia nigra, forebrain and midbrain. Mol Brain Res 1998;53:307-310
76. Rosengren E, Bucala R, Aman P, Jacobsson L, Odh G, Metz CN, Rorsman H. The immunoregulatory mediator macrophage migration inhibitory factor (MIF) catalyzes a tautomerization reaction. Mol Med 1996;2:143-149
77. Matsunaga J, Sinha D, Pannell L, Santis C, Solano F, Wistow GJ, Hearing VJ. Enzyme activity of macrophage migration inhibitory factor (MIF) towards oxidized catecholamines. J Biol Chem 1999;274:3268-3271
78. Wilhelmsen K, Mirel D, Marder K, Berstein M, Naini A, Leal SM, Cote LJ, Tang MX, Freyer G, Graziano J, Mayeux R. Is there a genetic susceptibility locus for Parkinson's disease on chromosome 22q13? Ann Neurol 1997;41:813-817
79. Esumi N, Budarf M, Ciccarelli L, Sellinger B, Kozak CA, Wistow GJ. Conserved gene structure and genomic linkage for D-dopachrome tautomerase (DDT) and MIF. Mamm Genome 1998;9:753-757